Cargando…

A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.

The EGF receptor is a transmembrane glycoprotein exerting mitogenic effects on epithelial cells. The purpose of the present study was to develop a sensitive enzyme-linked immunosorbent assay (ELISA) for determination of the epidermal growth factor receptor (EGFR) protein to examine whether the recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, M. E., Engbaek, F., Therkildsen, M. H., Bretlau, P., Nexø, E.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034104/
https://www.ncbi.nlm.nih.gov/pubmed/8519664
_version_ 1782136983493017600
author Christensen, M. E.
Engbaek, F.
Therkildsen, M. H.
Bretlau, P.
Nexø, E.
author_facet Christensen, M. E.
Engbaek, F.
Therkildsen, M. H.
Bretlau, P.
Nexø, E.
author_sort Christensen, M. E.
collection PubMed
description The EGF receptor is a transmembrane glycoprotein exerting mitogenic effects on epithelial cells. The purpose of the present study was to develop a sensitive enzyme-linked immunosorbent assay (ELISA) for determination of the epidermal growth factor receptor (EGFR) protein to examine whether the receptor was overexpressed in head and neck squamous cell carcinomas compared with the normal counterpart, and to establish whether clinicopathological correlations were present by investigating a broad spectrum of parameters (tumour size, clinical stage, positive lymph nodes, tumour site, histological grade, keratinisation, preoperative irradiation and clinical outcome). The assay employs two commercially available monoclonal antibodies, both detecting protein epitopes. The material comprises 60 head and neck carcinomas, corresponding normal tissue and normal oral mucosa from healthy individuals. The study demonstrates significantly higher receptor levels in tumours compared with normal tissue (P < 0.002) and a range in tumours and normal tissues of 0.4-10.5 and 0.1-4.3 nmol g-1 membrane protein respectively. Quantitation of receptors in normal mucosa emphasises the importance of using the patients' corresponding normal tissue, because using the patients' mucosa resulted in 83% overexpression, while using normal mucosa from healthy individuals only demonstrated overexpression in 50% of cases. No significant clinicopathological correlations could be established, although the mean values for EGFR increased with tumour size and advanced clinical stage. Furthermore, the prognostic value concerning disease-free survival, recurrence and the time interval for recurrence were investigated but no significance could be demonstrated. In conclusion, the investigation supports the theory of overexpression of EGFR protein as a common motif for malignant epithelial tumours, but limitations in interpretations are demonstrated and discussed further.
format Text
id pubmed-2034104
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20341042009-09-10 A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Christensen, M. E. Engbaek, F. Therkildsen, M. H. Bretlau, P. Nexø, E. Br J Cancer Research Article The EGF receptor is a transmembrane glycoprotein exerting mitogenic effects on epithelial cells. The purpose of the present study was to develop a sensitive enzyme-linked immunosorbent assay (ELISA) for determination of the epidermal growth factor receptor (EGFR) protein to examine whether the receptor was overexpressed in head and neck squamous cell carcinomas compared with the normal counterpart, and to establish whether clinicopathological correlations were present by investigating a broad spectrum of parameters (tumour size, clinical stage, positive lymph nodes, tumour site, histological grade, keratinisation, preoperative irradiation and clinical outcome). The assay employs two commercially available monoclonal antibodies, both detecting protein epitopes. The material comprises 60 head and neck carcinomas, corresponding normal tissue and normal oral mucosa from healthy individuals. The study demonstrates significantly higher receptor levels in tumours compared with normal tissue (P < 0.002) and a range in tumours and normal tissues of 0.4-10.5 and 0.1-4.3 nmol g-1 membrane protein respectively. Quantitation of receptors in normal mucosa emphasises the importance of using the patients' corresponding normal tissue, because using the patients' mucosa resulted in 83% overexpression, while using normal mucosa from healthy individuals only demonstrated overexpression in 50% of cases. No significant clinicopathological correlations could be established, although the mean values for EGFR increased with tumour size and advanced clinical stage. Furthermore, the prognostic value concerning disease-free survival, recurrence and the time interval for recurrence were investigated but no significance could be demonstrated. In conclusion, the investigation supports the theory of overexpression of EGFR protein as a common motif for malignant epithelial tumours, but limitations in interpretations are demonstrated and discussed further. Nature Publishing Group 1995-12 /pmc/articles/PMC2034104/ /pubmed/8519664 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Christensen, M. E.
Engbaek, F.
Therkildsen, M. H.
Bretlau, P.
Nexø, E.
A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
title A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
title_full A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
title_fullStr A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
title_full_unstemmed A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
title_short A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
title_sort sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034104/
https://www.ncbi.nlm.nih.gov/pubmed/8519664
work_keys_str_mv AT christensenme asensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT engbaekf asensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT therkildsenmh asensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT bretlaup asensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT nexøe asensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT christensenme sensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT engbaekf sensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT therkildsenmh sensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT bretlaup sensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations
AT nexøe sensitiveenzymelinkedimmunosorbentassayusedforquantitationofepidermalgrowthfactorreceptorproteininheadandneckcarcinomasevaluationinterpretationsandlimitations